Viewing Study NCT07003295


Ignite Creation Date: 2025-12-24 @ 1:18 PM
Ignite Modification Date: 2026-01-09 @ 7:44 PM
Study NCT ID: NCT07003295
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module